as 04-01-2025 3:36pm EST
Founded: | 1999 | Country: | Denmark |
Employees: | N/A | City: | N/A |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | $40.00 | AVG Volume (30 days): | 1.6M |
Analyst Decision: | Buy | Number of Analysts: | 10 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 16.85 | EPS Growth: | 83.82 |
52 Week Low/High: | $18.62 - $30.50 | Next Earning Date: | 05-01-2025 |
Revenue: | $2,988,286,182 | Revenue Growth: | 30.67% |
Revenue Growth (this year): | 19.81% | Revenue Growth (next year): | 13.94% |
GMAB Breaking Stock News: Dive into GMAB Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
Business Wire
a day ago
GlobeNewswire
2 days ago
Pharmaceutical Technology
5 days ago
Benzinga
5 days ago
MT Newswires
6 days ago
Business Wire
6 days ago
GlobeNewswire
7 days ago
The information presented on this page, "GMAB Genmab A/S ADS - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.